His Cancer is Stage four Duodenal Cancer with boney metastases he is MMR intact and has the BRCA1 positive. The...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
his Cancer is Stage four Duodenal Cancer with boney metastases he is MMR intact and has the BRCA1 positive. The other option is Bevacizumab injection avastin mvasi zirabev aybintio. Pain has increased a ton and now on Hydromorphone and getting weakness in left leg and knee losing mobility. We think from the dexamethazone. Radiation wants to do an MR1 to look at spine closer before radiating again but he cannot lie down flat for longer than a few minutes. Must be elevated or moving to stand the pain.
I can see you're navigating an incredibly challenging situation with your loved one's advanced cancer. Let me help clarify what's happening medically and what questions might be most important right now.
Understanding the Current Clinical Picture
Stage IV Duodenal Cancer with Bone Metastases: Your family member has cancer that originated in the duodenum (first part of small intestine) that has spread to bone—this is advanced disease. The PET scan confirms what oncologists call "FDG-avid lesions," meaning the cancer cells are metabolically active and showing up clearly on imaging. According to NCCN Guidelines for gastric and duodenal cancers, once disease has metastasized to bone, treatment shifts toward managing progression and symptoms rather than curative intent.
The Biomarker Profile (MMR intact, BRCA1 positive):
- MMR intact means the DNA mismatch repair system is working normally—this typically limits immunotherapy options
- BRCA1 positive is significant and somewhat unusual in duodenal cancer. According to NCCN Guidelines, BRCA mutations can influence treatment decisions, particularly regarding platinum-based chemotherapy sensitivity and potentially PARP inhibitor eligibility (though this is more established in other cancer types)
About Bevacizumab (Avastin/Mvasi/Zirabev/Aybintio): These are all bevacizumab—a targeted therapy that blocks blood vessel formation to tumors. It's FDA-approved for advanced gastric cancers and is sometimes used in duodenal cancer as part of combination regimens. The clinical reasoning: cutting off blood supply can slow tumor growth, but it doesn't address the underlying cancer directly—it's typically combined with chemotherapy.
The Immediate Medical Concerns
The Neurological Symptoms (Left Leg Weakness, Mobility Loss): This is urgent and needs immediate clarification with his oncology and radiation teams:
-
Is this spinal cord compression? Weakness + inability to lie flat + bone metastases = potential emergency. Spinal cord compression can progress rapidly and cause permanent paralysis if not addressed quickly.
-
Is this dexamethasone-related? Steroids can cause weakness, but they're often given to reduce swelling around spinal metastases. The timing matters—did weakness start after starting dexamethasone, or was it already present?
-
The MRI dilemma: Radiation oncology wants imaging to plan treatment safely, but he can't tolerate the positioning. This is a real clinical problem that needs creative solutions.
Critical Questions for His Care Team (TODAY/ASAP)
About the Neurological Symptoms:
- "Has spinal cord compression been ruled out? If not, what's the timeline for imaging to confirm?"
- "Could the leg weakness be from the dexamethasone, or is it more likely from tumor progression in the spine?"
- "If spinal cord compression is present, what are the emergency treatment options given his positioning limitations?"
About the MRI Positioning Problem: 4. "Are there alternatives to standard MRI positioning—like upright MRI, or can we do a limited protocol with less time flat?" 5. "If he cannot tolerate MRI, can CT or other imaging guide radiation planning instead?"
About Pain Management: 6. "Is the pain increase from tumor progression, or could it be related to the dexamethasone or other medications?" 7. "Are there additional pain management options beyond hydromorphone—like nerve blocks, regional anesthesia, or palliative radiation to bone metastases?"
About Treatment Direction: 8. "Given the rapid progression on PET scan and current symptoms, what is the realistic goal of continued systemic treatment—extending survival, controlling symptoms, or both?"
What You Should Know About This Stage
According to the American Cancer Society and NCCN Guidelines, Stage IV duodenal cancer with bone metastases and rapid progression (as shown on your PET scan) typically has a median survival measured in months. This doesn't mean treatment is futile—it means the focus often shifts toward:
- Symptom control (pain, weakness, mobility)
- Quality of life (ability to be comfortable, spend time with family)
- Selective treatment (choosing interventions that help without causing more burden)
The dexamethasone helping with swelling but causing weakness is a classic oncology dilemma—sometimes the treatment side effects become the main problem.
The Immediate Priority
The leg weakness and inability to lie flat are RED FLAGS. These need urgent evaluation TODAY, not next week. If this is spinal cord compression, delays can mean permanent disability. Call the radiation oncology team and say: "He's developed acute leg weakness and cannot tolerate positioning for MRI. We need urgent evaluation for spinal cord compression."
If it's dexamethasone-related, his oncologist may need to adjust the dose or add physical therapy. But you can't know which without asking directly.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
I'm genuinely sorry you're facing this. The combination of advanced cancer, pain, and neurological symptoms is overwhelming. Your advocacy for getting clear answers about what's causing the leg weakness could be the most important thing right now.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with treatment for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ